About Zinc finger protein 597
Zinc finger protein 597 (ZNF597) is a protein
from Homo sapiens identified by UniProt accession
Q96LX8, 424 residues long.
MolForge cross-references it against 0 known binders and
71 disease associations.
Target properties
| Protein name | Zinc finger protein 597 |
| UniProt accession | Q96LX8 |
| Gene | ZNF597 |
| Organism | Homo sapiens |
| Length | 424 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (71)
Diseases linked to this target (Open Targets).
- insulin like growth factor measurement · score 0.23
- body height · score 0.13
- IGF-1 measurement · score 0.06
- Familial ocular anterior segment mesenchymal dysgenesis · score 0.06
- eosinophil count · score 0.06
- X-linked intellectual disability-retinitis pigmentosa syndrome · score 0.05
- Peters anomaly · score 0.05
- iridocorneal endothelial syndrome · score 0.05
- Rieger anomaly · score 0.05
- spinocerebellar ataxia type 17 · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96LX8-F1 | alphafold | PREDICTED | 48.76 | — |
Amino-acid sequence (424 residues)
MASMPPTPEA QGPILFEDLA VYFSQEECVT LHPAQRSLSK DGTKESLEDA ALMGEEGKPE INQQLSLESM ELDELALEKY PIAAPLVPYP EKSSEDGVGN PEAKILSGTP TYKRRVISLL VTIENHTPLV ELSEYLGTNT LSEILDSPWE GAKNVYKCPE CDQNFSDHSY LVLHQKIHSG EKKHKCGDCG KIFNHRANLR THRRIHTGEK PYKCAKCSAS FRQHSHLSRH MNSHVKEKPY TCSICGRGFM WLPGLAQHQK SHSAENTYES TNCDKHFNEK PNLALPEETF VSGPQYQHTK CMKSFRQSLY PALSEKSHDE DSERCSDDGD NFFSFSKFKP LQCPDCDMTF PCFSELISHQ NIHTEERPHK CKTCEESFAL DSELACHQKS HMLAEPFKCT VCGKTFKSNL HLITHKRTHI KNTT
Explore Zinc finger protein 597 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets